Choosing the best bank in India is not just about brand recall. It is about asset quality, net interest margins, return ratios, dividend consistency, and how the stock behaves in volatile markets. In 2027, three names dominate every banking discussion: HDFC Bank, State Bank of India (SBI), and Punjab National Bank (PNB). Each represents a different banking philosophy — private sector agility, public sector scale, and PSU turnaround.

This article gives you a full depth analysis of all three banks, their recent stock movements, quarterly performance, comparison tables, and what brokerages are saying right now.
What Makes a Bank “Best” in India?
Before diving into numbers, here are the key metrics that matter:
| Parameter | Why It Matters |
|---|---|
| Net Interest Margin (NIM) | Core profitability from lending |
| Gross NPA / Net NPA | Asset quality — lower is better |
| Return on Assets (ROA) | How efficiently the bank uses its assets |
| Capital Adequacy Ratio (CAR) | Safety buffer against loan losses |
| CASA Ratio | Low-cost deposits — higher is better |
| Dividend Yield | Income for long-term investors |
A “best bank” in India must excel across asset quality, profitability, and shareholder returns — not just one metric.
Q2 FY27 Scorecard: Side by Side
| Metric (Q2 FY27) | SBI | PNB | HDFC Bank |
|---|---|---|---|
| Net profit | ₹23,038 crore | ₹5,532 crore | ₹19,510 crore |
| Profit growth YoY | +14.3% | +12.8% | +4.7% |
| Net interest income | ₹49,143 crore | ₹11,601 crore | ₹34,619 crore |
| NII growth YoY | +14.7% | +10.8% | +9.7% |
| Net interest margin | 3.11% (domestic) | 2.58% | 3.16% |
| Gross NPA | 1.39% | 2.55% | 1.11% |
| Net NPA | 0.36% | 0.25% | 0.37% |
| Share price reaction | Muted | Up 8% | Down 1.5–2% |
Two cautions. SBI’s profit includes a ₹7,288 crore one-off gain from the SBI MF divestment. HDFC Bank’s profit was held back by a 67% drop in treasury gains.
Strip those out and the picture flips. HDFC’s profit excluding treasury grew 12.6%. SBI’s core earnings were soft.
1. State Bank of India (NSE: SBIN)
SBI is India’s largest bank. Q2 FY27 profit jumped 14.3% to ₹23,038 crore, but ₹7,288 crore came from a one-off. NII grew 14.7%. Gross NPA fell to 1.39%, the lowest in over 20 years. At about 1.5x book, it is still cheap.
52-Week Range and Key Numbers
| Metric | Value |
|---|---|
| Price | about ₹975 |
| 52-week low / high | about ₹882 / ₹1,234.70 |
| Distance from high | about 21% below |
| Market cap | about ₹8.9 lakh crore |
| P/E (TTM) | 10–11x |
| P/B | about 1.5x |
| Dividend yield | about 1.8% |
| ROE (H1 FY27) | 18.7% (boosted by the one-off) |
Latest Results
| Metric | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Net profit | ₹23,038 crore | ₹20,160 crore | +14.3% |
| Net interest income | ₹49,143 crore | ₹42,847 crore | +14.7% |
| Operating profit | ₹34,226 crore | about ₹32,000 crore | about +7% |
| Exceptional gain | ₹7,288 crore | ₹4,593 crore (Yes Bank sale) | |
| Gross NPA | 1.39% | 1.73% | down 34 bps |
| Net NPA | 0.36% | 0.42% | down 6 bps |
| Slippage ratio | 0.50% | – | – |
H1 FY27 profit is ₹44,159 crore (EPS ₹47.84). Sequentially, profit rose 9% from ₹21,121 crore in Q1. Sources differ on year-on-year operating profit growth, so I use a rounded figure.
Forecast Till 2030 (My Estimates)
FY27 includes the one-off. I assume 8–9% a year core growth after that.
| Year | NII (₹ lakh crore) | Net Profit (₹ crore) | EPS (₹) |
|---|---|---|---|
| TTM (to Sep 26) | about 1.87 | about 86,000 | about 87 |
| FY27E | about 1.96 | about 83,000 | about 93 |
| FY28E | about 2.16 | about 90,000 | about 101 |
| FY29E | about 2.38 | about 98,000 | about 110 |
| FY30E | about 2.60 | about 107,000 | about 120 |
Price Target
| Scenario | 12-Month Value | Basis |
|---|---|---|
| Bear | ₹800 | About 8x FY28E EPS, margins compress |
| Base | ₹1,150 | About 11.4x FY28E EPS of ~₹101, subsidiaries included |
| Bull | ₹1,350 | About 13x EPS, NIM recovers above 3.3% |
Analyst and Brokerage Ratings
| Brokerage | Rating | Target |
|---|---|---|
| JP Morgan (post-Q2) | Overweight | ₹1,295 |
| Citi (post-Q2) | Buy | ₹1,300 |
| Emkay (May 2026, pre-Q2) | Buy | ₹1,225 |
| HSBC | Reassessed after Q2 | Not confirmed |
JP Morgan raised FY27–29 earnings estimates by 4–8%. My base target sits below the street. That is deliberate. I discount the one-off.
Future Growth Potential
- Loan growth is running ahead of deposits. That is growth, but watch funding.
- Domestic NIM at 3.11% has room to recover as deposit costs fall.
- Subsidiary value (SBI Life, SBI Cards, SBI MF) adds roughly 20–25% to the core bank value in most brokerage models.
- Cyber resilience centre and tech spend support long-run efficiency.
Bull vs Bear
| Bull Case | Bear Case |
|---|---|
| NIM recovers as deposit costs fall | Core profit stays flat |
| Credit cost stays near zero | Loans outgrow deposits, funding tightens |
| Subsidiary unlocking continues | Listed subsidiary SBI Funds is 24% below issue price |
| Dividend and buybacks support the price | PSU policy or wage cost shocks |
Key Risks
- Quality of earnings. One-off gains flattered two years in a row.
- Operating profit. Soft year on year once you adjust.
- Funding. Loans growing faster than deposits.
- SMA movement. Management says more than half of stressed loans were pulled back to standard. Watch it.
My call: Buy. Add below ₹950.
2. HDFC Bank (NSE: HDFCBANK)
HDFC Bank is India’s largest private lender. Q2 profit rose just 4.7% to ₹19,510 crore, but profit excluding treasury grew 12.6%. NIM slipped to 3.16%. The stock is down 23% in a year and hit lows near ₹669. Anup Bagchi is the new MD and CEO.
52-Week Range and Key Numbers
| Metric | Value |
|---|---|
| Price | ₹760 |
| 52-week low / high | about ₹669 / ₹1,017.50 (bonus-adjusted) |
| Distance from high | about 25% below |
| Market cap | about ₹11.7 lakh crore |
| P/E (TTM) | about 15x |
| P/B | about 2.0x (book value about ₹378) |
| ROE | about 13.3% |
| 1-year return | about -23% |
Latest Results
| Metric | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Net profit (standalone) | ₹19,510 crore | ₹18,641 crore | +4.7% |
| Profit excluding treasury | ₹18,930 crore | ₹16,810 crore | +12.6% |
| Net interest income | ₹34,619 crore | ₹31,550 crore (approx.) | +9.7% |
| NIM | 3.16% | – | down from 3.26% in Q1 |
| Gross advances | – | – | +16.3% |
| Deposits | – | – | +18.8% |
| Gross NPA / Net NPA | 1.11% / 0.37% | 1.24% / 0.42% | better |
| Provisions | ₹3,574 crore | – | – |
| EPS | ₹12.7 | ₹12.1 | – |
One source reports flat profit of ₹18,610 crore. Most sources, including the bank’s own coverage, show ₹19,510 crore. I use the latter. Core operating profit was about ₹28,700 crore, up 12%.
Forecast Till 2030 (My Estimates)
| Year | NII (₹ lakh crore) | Net Profit (₹ crore) | EPS (₹) |
|---|---|---|---|
| TTM (to Sep 26) | about 1.33 | about 77,000 | about 50 |
| FY27E | about 1.38 | about 83,000 | about 54 |
| FY28E | about 1.58 | about 95,000 | about 62 |
| FY29E | about 1.80 | about 109,000 | about 71 |
| FY30E | about 2.05 | about 123,000 | about 80 |
I assume NIM bottoms near 3.1% and loan growth settles near 14–15%.
Price Target
| Scenario | 12-Month Value | Basis |
|---|---|---|
| Bear | ₹640 | 1.5x book, NIM falls below 3% |
| Base | ₹920 | 15x FY28E EPS of ~₹62 |
| Bull | ₹1,100 | 18x EPS, margin and ROE recover |
Analyst and Brokerage Ratings
| Brokerage | Rating | Target |
|---|---|---|
| Bernstein | Outperform | ₹1,150 |
| JP Morgan | Overweight | ₹970 (cut from ₹990) |
| Nomura | Buy | ₹940 |
| Citi | Buy | Lowered, still Buy |
| Jefferies | Positive | Low end of the ₹880–1,150 range |
Target prices cluster at ₹880 to ₹1,150. Analysts said the worst is over after Q2.
Future Growth Potential
- Deposit growth of 18.8% is faster than loan growth. That lowers funding stress over time.
- Merger-related balance sheet cleanup is largely done.
- NIM can recover as the cost of funds falls.
- A new leadership team (Chairman Rajiv Kumar, MD and CEO Anup Bagchi) can reset the narrative.
- 9,706 branches and 20,881 ATMs across 4,177 locations.
Bull vs Bear
| Bull Case | Bear Case |
|---|---|
| Margin bottoms, EPS grows 15% a year | NIM keeps falling |
| New CEO restores confidence | Further senior exits (the CFO retires this month) |
| Re-rating from 2.0x towards 2.5x book | ROE stays near 13% |
| Treasury income normalises | Treasury gains stay weak |
Key Risks
- Margins. NIM fell 10 bps in one quarter.
- Leadership transition. New CEO, new chairman and a CFO retiring.
- ROE. Below the premium the stock once earned.
- Valuation. About 2x book is not cheap against SBI.
My call: Buy in tranches. Accumulate between ₹720 and ₹770.
3. Punjab National Bank (NSE: PNB)
PNB is India’s second-largest public sector bank by assets. Q2 FY27 profit rose 12.8% to ₹5,532 crore. NIM improved to 2.58%. Core operating profit jumped 29%. Shares rose 8% on results. It trades near 1x book and about 7x earnings. Gross NPA of 2.55% is still the highest here.
52-Week Range and Key Numbers
| Metric | Value |
|---|---|
| Price | ₹126.10 |
| 52-week low / high | ₹98.50 / ₹135.15 |
| Market cap | about ₹1.45 lakh crore |
| P/E (TTM) | about 6.9x (EPS ₹18.37) |
| P/B | about 0.95x (book value about ₹130) |
| Dividend yield | about 2.4% |
| Government holding | 70.08% |
Latest Results
| Metric | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Net profit | ₹5,532 crore | ₹4,904 crore | +12.8% |
| Net interest income | ₹11,601 crore | ₹10,469 crore | +10.8% |
| Operating profit | ₹7,532 crore | – | +4.2% |
| Core operating profit | ₹5,971 crore | – | +29.4% |
| Global NIM | 2.58% | – | up from 2.50% in Q1 |
| Gross NPA / Net NPA | 2.55% / 0.25% | – | improved |
| Capital adequacy | 17.95% | – | – |
| Fee income | ₹1,954 crore | – | +16% |
| Global advances | ₹13.41 lakh crore | ₹11.70 lakh crore | +14.7% |
| Global deposits | ₹17.77 lakh crore | ₹16.17 lakh crore | +9.9% |
Core operating profit now makes up 79% of the total, versus 64% a year ago. That is the best sign in the report. The weak spot: slippage ratio rose to 0.77% from 0.71%.
Forecast Till 2030 (My Estimates)
| Year | NII (₹ crore) | Net Profit (₹ crore) | EPS (₹) |
|---|---|---|---|
| TTM (to Sep 26) | 43,313 | 21,111 | 18.4 |
| FY27E | about 46,500 | about 23,300 | about 20 |
| FY28E | about 52,000 | about 26,500 | about 23 |
| FY30E | about 62,000 | about 33,500 | about 29 |
Management guides to ROA above 1% and credit cost of 0.25–0.30%. I assume it gets there by FY28.
Price Target
| Scenario | 12-Month Value | Basis |
|---|---|---|
| Bear | ₹95 | About 0.7x book, one-time ECL hit hurts |
| Base | ₹140 | About 6.1x FY28E EPS of ~₹23 |
| Bull | ₹170 | About 7.2x EPS, ROA crosses 1% |
Analyst and Brokerage Ratings
| Brokerage | Rating | Target |
|---|---|---|
| Jefferies | Buy | ₹140 |
| Motilal Oswal | Buy | ₹140 |
| JM Financial | Buy (upgraded from Add) | ₹140 (from ₹120) |
| Citi | Sell | ₹110 |
The street is mostly positive, with one clear dissenter. Note the targets cluster at ₹140. After an 8% jump, that leaves about 11% upside.
Future Growth Potential
- MSME advances grew 19.8% to ₹2.15 lakh crore.
- NIM guided to 2.6–2.8%, up from 2.58%.
- Core earnings are replacing recoveries and treasury as the profit driver.
- Government ownership of 70% gives it a capital backstop.
Bull vs Bear
| Bull Case | Bear Case |
|---|---|
| ROA moves above 1% | One-time ECL impact (guided at ₹8,000 crore) |
| Valuation re-rates from 1x to 1.3x book | Recovery income dries up |
| Credit cost stays at 0.25–0.30% | Slippages keep creeping up |
Key Risks
- Asset quality. Gross NPA of 2.55% is the weakest of the three.
- ECL transition. A one-time hit is coming under the new provisioning norms.
- Deposit growth of 9.9% lags loan growth of 14.7%.
- Momentum. The stock jumped 8% in a day.
My call: Accumulate on dips toward ₹115–120.
Comparison Table: SBI vs PNB vs HDFC Bank
| Factor | SBI | PNB | HDFC Bank |
|---|---|---|---|
| Price | ₹975 | ₹126 | ₹760 |
| Market cap | ₹8.9 lakh crore | ₹1.45 lakh crore | ₹11.7 lakh crore |
| P/E (TTM) | 10–11x | ~6.9x | ~15x |
| P/B | ~1.5x | ~0.95x | ~2.0x |
| Dividend yield | ~1.8% | ~2.4% | ~1.5% |
| Gross NPA | 1.39% | 2.55% | 1.11% |
| NIM | 3.11% | 2.58% | 3.16% |
| Q2 profit growth | +14.3% | +12.8% | +4.7% |
| 52-week range | ₹882–1,235 | ₹98.5–135 | ₹669–1,018 |
| 12-month target | ₹1,150 | ₹140 | ₹920 |
| Street range | ₹1,295–1,300 | ₹110–140 | ₹880–1,150 |
| My call | Buy | Accumulate | Buy |
Scenario Summary: Where Do Bank Stocks Go?
Base case.
Rates settle. Deposit costs ease. Loan growth stays at 12–15%. Credit costs stay below 0.5%. SBI earns about ₹100 a share by FY28 and trades near ₹1,150. HDFC Bank’s NIM bottoms and EPS grows 15% a year. It gets back to ₹920. PNB delivers ROA near 1% and trades around ₹140. Each stock gains 11–21% in 12 months, plus dividends.
Bull case.
Deposit costs fall faster than loan yields. NIMs recover across all three. HDFC’s new CEO restores the premium and it trades near ₹1,100. SBI and PNB re-rate as PSU credit quality gets recognised. SBI reaches ₹1,350. PNB reaches ₹170.
Bear case.
Margins keep compressing. Credit costs rise. Deposits get harder to find. SBI’s one-offs stop. HDFC’s transition drags. PNB’s ECL hit hits capital. SBI falls to ₹800, HDFC to ₹640 and PNB to ₹95.
The pattern is simple. All three are priced for caution. The best margin of safety is SBI. The best quality is HDFC Bank. The best pure value is PNB.
Which Bank Is Best for You?
The answer depends on your investment style:
Choose HDFC Bank if: You want India’s strongest private banking franchise with the best asset quality, but you are willing to wait for the valuation re-rating. Brokerage targets suggest 19–40% upside from current levels.
Choose SBI if: You want the safety of a government-backed institution with improving profitability, strong dividend, and a more reasonable valuation than HDFC Bank. SBI offers the best balance of safety and returns.
Choose PNB if: You are a value investor willing to take higher risk for potentially higher returns. PNB’s P/B of 0.97 and dividend yield of 2.57% are attractive, but NIM compression and Goldman Sachs’ Sell rating are red flags.
For most Indian investors, a combination of HDFC Bank and SBI covers both private sector quality and public sector value. PNB works best as a satellite holding for investors with a higher risk appetite.
Final Verdict
India’s banking sector in 2026 is a story of divergence. HDFC Bank, despite its pristine asset quality and dominant franchise, is in a valuation correction phase. SBI is delivering steady growth with improving asset quality and attractive dividends. PNB, the smallest of the three, offers the deepest value but with the highest execution risk.
The best bank in India is not one name — it is the one that fits your risk profile, time horizon, and return expectations. HDFC Bank remains the quality benchmark. SBI remains the safest large-cap bet. PNB remains the high-risk, high-reward turnaround play.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Stock prices and financial data are subject to change.
Frequently Asked Questions
There is no single “best” bank for everyone. HDFC Bank offers the strongest private-sector franchise and asset quality. SBI offers the best balance of safety, scale, and dividend. PNB offers deep value but higher risk. For most investors, HDFC Bank and SBI together make a strong core banking portfolio.
HDFC Bank has better asset quality and NIM, while SBI has a larger asset base, stronger government backing, and a lower valuation. HDFC Bank is a quality pick; SBI is a value-plus-safety pick. Both can coexist in a portfolio.
PNB trades at a low P/E of 6.55 and P/B of 0.97, with a dividend yield of 2.57%. Its asset quality has improved sharply. However, NIM compression and a Goldman Sachs Sell rating mean it is suitable only for investors with a higher risk appetite.
PNB has the highest dividend yield at approximately 2.57%, followed by HDFC Bank at 1.78–1.85% and SBI at 1.70%.
HDFC Bank: Gross NPA 1.17%, Net NPA 0.41%
SBI: Gross NPA 1.49%, Net NPA 0.39%
PNB: Gross NPA 2.95%, Net NPA 0.29%
Read Also –
Best 3 Stocks From India’s Recycling Boom? https://dailystocks7.com/2026/09/14/3-stocks-winning-from-indias-recycling-boom/
best Healthcare Stocks in India For Invest? https://dailystocks7.com/2026/09/13/indias-pharma-boom-best-crdmo-stocks-in-india/
3 Tiny Stocks Linked to Growing Space Economy? https://dailystocks7.com/2026/09/13/top-3-tiny-stocks-linked-to-the-growing-space-economy-in-2026/
Best Critical Mineral Stocks For Investments? https://dailystocks7.com/2026/09/12/critical-mineral-stocks-that-could-explode-during-the-ai-boom/
Best Penny Stocks Under $5 in USA? https://dailystocks7.com/2026/09/11/best-5-penny-stocks-under-5-in-usa/
Leave a Reply